Thrivent Financial for Lutherans’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,445
Closed -$1.07M 2414
2022
Q1
$1.07M Hold
15,445
﹤0.01% 1786
2021
Q4
$1.23M Hold
15,445
﹤0.01% 1720
2021
Q3
$1.23M Hold
15,445
﹤0.01% 1699
2021
Q2
$1.23M Hold
15,445
﹤0.01% 1712
2021
Q1
$1.01M Hold
15,445
﹤0.01% 1862
2020
Q4
$860K Buy
+15,445
New +$668K ﹤0.01% 1851
2014
Q4
Sell
-14,400
Closed -$212K 1863
2014
Q3
$212K Hold
14,400
﹤0.01% 1565
2014
Q2
$265K Buy
+14,400
New +$240K ﹤0.01% 1465

Other funds holding ATRC

Thrivent Financial for Lutherans's ATRC Position: Q2 2022 in Review

Thrivent Financial for Lutherans sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 15,445 shares — an estimated $1.07M sold.

Thrivent Financial for Lutherans first reported a position in ATRC in Q2 2014 and held it in 8 quarters. The position peaked at $1.23M in Q4 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

  • Thrivent Financial for Lutherans reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 15,445 AtriCure shares in Q2 2022, an estimated $1.07M.
  • Thrivent Financial for Lutherans first reported a position in AtriCure in Q2 2014 and held it in 8 quarters.
  • Thrivent Financial for Lutherans's AtriCure position peaked at $1.23M in Q4 2021.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2022, filed 16 Aug 2022.